Detalhe da pesquisa
1.
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
Cell
; 182(5): 1252-1270.e34, 2020 09 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32818467
2.
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 389(24): 2256-2266, 2023 Dec 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37870955
3.
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Nature
; 585(7823): 107-112, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32728218
4.
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Lancet
; 402(10404): 798-808, 2023 09 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37451295
5.
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 385(13): 1196-1206, 2021 09 23.
Artigo
Inglês
| MEDLINE | ID: mdl-34551229
6.
Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease.
Ann Rheum Dis
; 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38561219
7.
Molecular prediction of clinical response to anti-PD-1/anti-PD-L1 immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry-based investigations.
Int J Cancer
; 153(2): 252-264, 2023 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36408912
8.
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Lancet
; 400(10358): 1117-1129, 2022 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36099927
9.
Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma.
Cancer Immunol Immunother
; 72(2): 509-513, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35841421
10.
The prognostic value of [18F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria.
Eur J Nucl Med Mol Imaging
; 50(9): 2699-2714, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37099131
11.
Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma.
Eur J Nucl Med Mol Imaging
; 50(4): 1158-1167, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36474125
12.
Can physiologic colonic [18F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
Eur J Nucl Med Mol Imaging
; 50(12): 3709-3722, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37452874
13.
Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study.
J Eur Acad Dermatol Venereol
; 37(5): 884-893, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36433671
14.
Checkpoint blocker induced autoimmunity as an indicator for tumour efficacy in melanoma.
Br J Cancer
; 126(2): 163-164, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34697417
15.
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment.
Cancer Immunol Immunother
; 71(8): 2051-2056, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34940894
16.
Distinct immune-effector and metabolic profile of CD8+ T cells in patients with autoimmune polyarthritis induced by therapy with immune checkpoint inhibitors.
Ann Rheum Dis
; 2022 Aug 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35922125
17.
Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy.
Strahlenther Onkol
; 198(10): 884-891, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35546362
18.
Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imaging.
Q J Nucl Med Mol Imaging
; 66(3): 245-254, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35612369
19.
Targeted Therapy for Melanomas Without BRAF V600 Mutations.
Curr Treat Options Oncol
; 23(6): 831-842, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35380338
20.
Tebentafusp for the treatment of metastatic uveal melanoma.
Future Oncol
; 18(11): 1303-1311, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35172589